NeuroVision Garners $5,000,000 Series B Financing Round

  • Feed Type
  • Date
    6/30/2016
  • Company Name
    NeuroVision
  • Mailing Address
    1395 Garden Hwy Sacramento, CA 95833 USA
  • Company Description
    NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease.
  • Website
    http://www.neurovision.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Wildcat Capital Management
  • Venture Investor
    Investor

Trending on Xconomy